Gilead Sciences, Inc. · NASDAQ:GILD

Dickinson Andrew D sold 3,000 Gilead Sciences, Inc. shares (Form 4)

Traded Sep 15, 2026 · Filed Sep 16, 2026

On Sep 15, 2026, Dickinson Andrew D (Chief Financial Officer) sold 3,000 Gilead Sciences, Inc. shares at US$145.29 for US$436K under a trading plan, leaving 164,096 shares. Filed Sep 16, 2026 (Form 4).

Sold
3,000 shares
Price
US$145.29
Value
US$436K
Holding after
164,096 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common StockSale3,000US$145.29164,096Direct

Source

View original at SEC

Related